Carl Sailer insider trades: Acurx Pharmaceuticals (ACXP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Carl reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | ACXP | ↑ Buy | 24,631 | $1.01 | $25K | Direct | Jan 8, 2025 (2d) |
| Jul 27, 2022 | ACXP | ↑ Buy | 19,737 | $3.80 | $75K | Direct | Jul 29, 2022 (2d) |
| Nov 23, 2021 | ACXP | ↑ Buy | 5,161 | $4.84 | $25K | Direct | Nov 24, 2021 (1d) |
| Jun 29, 2021 | ACXP | ↑ Buy | 12,500 | $6.00 | $75K | Direct | Sep 10, 2021 (73d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Carl Sailer's insider trades
Carl Sailer is a director at Acurx Pharmaceuticals (ACXP). Since Jun 29, 2021, Carl has reported 4 open-market purchases worth $200K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.